Geneos Wealth Management’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-338
Closed -$49.1K – 2887
2025
Q2
$49.1K Sell
338
-2
-0.6% -$289 ﹤0.01% 1578
2025
Q1
$43K Buy
340
+131
+63% +$16.6K ﹤0.01% 1569
2024
Q4
$21.7K Hold
209
– – ﹤0.01% 1691
2024
Q3
$17.8K Buy
+209
New +$16.2K ﹤0.01% 1599

Other funds holding LRN

Geneos Wealth Management's LRN Position: Q3 2025 in Review

Geneos Wealth Management sold out of Stride (LRN) in Q3 2025, closing a stake of 338 shares — an estimated $49.1K sold.

Geneos Wealth Management first reported a position in LRN in Q3 2024 and held it in 4 quarters. The position peaked at $49.1K in Q2 2025. 518 funds tracked by Wall St. Rank hold LRN as of Q3 2025.

  • Geneos Wealth Management reported no remaining Stride position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 338 Stride shares in Q3 2025, an estimated $49.1K.
  • Geneos Wealth Management first reported a position in Stride in Q3 2024 and held it in 4 quarters.
  • Geneos Wealth Management's Stride position peaked at $49.1K in Q2 2025.
  • 518 funds tracked by Wall St. Rank held Stride as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.